Track: Valvular Heart Disease

Cardio Care Conference 2025

The "Valvular Heart Disease" session will explore the latest advancements in diagnosing and treating valvular heart conditions, focusing on how innovative technologies are transforming patient care. The session will highlight groundbreaking treatments like transcatheter valve therapies and minimally invasive valve surgeries, which are enhancing outcomes and significantly reducing recovery times. With these innovations, this session will offer a comprehensive look at the future of valvular heart disease management, providing new hope for better patient outcomes and quality of life.

Stenotic Valve Disorders: Understand the impact of conditions like aortic stenosis, pulmonary stenosis, and mitral stenosis, which involve narrowing of the valve openings. These disorders obstruct blood flow, increasing strain on the heart and often requiring surgical or interventional solutions.

Regurgitant Valve Disorders: Discover how mitral regurgitation, tricuspid regurgitation, and aortic regurgitation result in blood leakage due to incomplete valve closure. These conditions compromise cardiac efficiency and may lead to heart failure if untreated.

Valve Repair and Replacement: Explore advanced options for valve repair and replacement, including the use of mechanical and bioprosthetic valves. These procedures are tailored to patient-specific factors like age, lifestyle, and the need for long-term anticoagulation.

Surgical and Interventional Treatment Options: Gain insights into cutting-edge techniques like TAVI (Transcatheter Aortic Valve Implantation) and minimally invasive valve surgeries. These procedures offer alternatives to traditional surgery, enhancing recovery and reducing complications.

Genetic and Environmental Factors in VHD: Learn how genetic conditions like bicuspid aortic valve and environmental factors like rheumatic fever contribute to valvular heart disease. These insights aid in early detection, prevention, and management of VHD.